The post Marvel Star Djimon Hounsou Admits He's 'Struggling To Make a Living'—One Year After Renting Out L.A. Home appeared ...
We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the ...
Viking® ( (NYSE: VIK) today announced the Explorers’ Sale, providing North American travelers with new booking incentives ...
JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing opportunities in T2D/obesity and competitive clinical data insights.
Viking Therapeutics Inc (VKTX) stock saw a decline, ending the day at $38.88 which represents a decrease of $-0.43 or -1.09% from the prior close of $39.31. The stock opened at $38.25 and touched a ...
Viking Therapeutics (VKTX) has received a new Buy rating, initiated by Stifel Nicolaus analyst, Annabel Samimy.Stay Ahead of the ...
Viking has announced the launch of its Explorers' Sale, providing North American travelers with new booking incentives across ...
Viking Therapeutics only has a current market cap of $4.3 billion, with an EV in the range of $3.4 billion. The biotech has a cash balance of $930 million to provide the funding for the big GLP-1 ...
Jorvik Viking Festival, is set to celebrate its 40th year in York from February 17 to 23 with a wide range of activities designed to ...